Chronic conditions: The impact of delayed detection
Early detection of chronic diseases matters to the bottom line.
Read More
Study: Cardiodiabesity prevention key to improving health outcomes and lowering costs
The Evernorth Research Institute analyzed aggregated and anonymized data of almost 5 million insured individuals to understand the prevalence of "cardiodiabesity" — a condition which encompasses cardi...
Read More
Designing plans to manage comorbid conditions
Health plans that address and manage complex chronic conditions such as cardiovascular disease, obesity, and diabetes have a competitive advantage.
Read More
Tipping the scales to effectively treat obesity
The promise and challenges of semaglutide, a new therapy for weight loss
Read More
Addressing obesity in the workplace
As more people turn to diabetes medication to manage their weight, obesity has become a pressing concern for employers.
Read More
GLP-1s Medications 101
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population in the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...
Read More